- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
HeartBeam is a health information services business based in the US. HeartBeam shares (BEAT) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.48 – an increase of 9.25% over the previous week. HeartBeam employs 15 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Heartbeam stock
- Trade $0 commission stocks, ETFs, and options with as little as $1
- After-hours trading available
- Earn 4.5% interest on uninvested cash with Gold
- 24/7 customer support
- $0 commission trading
- Instant withdrawals with a 1.75% fee
- Supports 250+ cryptocurrencies
- High-yield account earns up to 4.65% APY
Disclaimer: This page is not financial advice or an endorsement of digital assets, providers or services. Digital assets are volatile and risky, and past performance is no guarantee of future results. Potential regulations or policies can affect their availability and services provided. Talk with a financial professional before making a decision. Finder or the author may own cryptocurrency discussed on this page.
How to buy HeartBeam stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – BEAT. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy HeartBeam stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
HeartBeam stock price (NASDAQ: BEAT)
Use our graph to track the performance of BEAT stocks over time.HeartBeam shares at a glance
Latest market close | $2.48 |
---|---|
52-week range | $1.06 - $3.39 |
50-day moving average | $2.28 |
200-day moving average | $2.25 |
Wall St. target price | $5.00 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-0.67 |
Is it a good time to buy HeartBeam stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
HeartBeam price performance over time
Historical closes compared with the close of $2.5 from 2024-11-19
1 week (2024-11-15) | 9.17% |
---|---|
1 month (2024-10-22) | 14.68% |
3 months (2024-08-22) | 10.62% |
6 months (2024-05-22) | 5.93% |
1 year (2023-11-22) | 83.84% |
---|---|
2 years (2022-11-22) | -41.04% |
3 years (2021-11-22) | 4.04 |
5 years (2019-11-18) | N/A |
HeartBeam financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -69.75% |
Return on equity TTM | -113.62% |
Profit margin | 0% |
Book value | $0.61 |
Market Capitalization | $60.5 million |
TTM: trailing 12 months
HeartBeam share dividends
We're not expecting HeartBeam to pay a dividend over the next 12 months.
You may also wish to consider:
- Medtronic (MDT.US) (3.18% forward annual dividend yield)
- CVS Health (CVS.US) (4.9% forward annual dividend yield)
HeartBeam share price volatility
Over the last 12 months, HeartBeam's shares have ranged in value from as little as $1.06 up to $3.3893. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while HeartBeam's is -0.987. This would suggest that HeartBeam's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, HeartBeam has bucked the trend.
To put HeartBeam's beta into context you can compare it against those of similar companies.
- Medtronic (MDT.US): 0.853
- CVS Health (CVS.US): 0.543
- DaVita HealthCare Partners (DVA.US): 0.887
HeartBeam overview
HeartBeam, Inc. , a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California. .
Frequently asked questions
What percentage of HeartBeam is owned by insiders or institutions?Currently 29.246% of HeartBeam shares are held by insiders and 8.732% by institutions. How many people work for HeartBeam?
Latest data suggests 15 work at HeartBeam. When does the fiscal year end for HeartBeam?
HeartBeam's fiscal year ends in December. Where is HeartBeam based?
HeartBeam's address is: 2118 Walsh Avenue, Santa Clara, CA, United States, 95050 What is HeartBeam's ISIN number?
HeartBeam's international securities identification number is: US42238H1086
More guides on Finder
-
Axos Bank Bonus Offers in November 2024
The $500 Axos Bank bonus is now expired, but you can still earn $50 per qualifying referral, plus up to $400 with a new business account.
-
Priority Plus Financial: Pushes Debt Relief Over Loans
Find out if Priority Plus Financial’s advertised loans are worth it or just a sales hook.
-
Xmas Loans: What, Where & How to Get Holiday Cash (2024)
Where to get a holiday loan in 2024 and whether it makes sense for you.
-
Modak vs. Greenlight: Which Kids’ Card Is Worth It?
Modak has no monthly fee, but it’s slim on features. Greenlight starts at $5.99 but is a value for big families.
-
Revenue-Based Business Loans: How Do They Work?
Get the capital your business needs to grow with repayments that adapt to your revenue.
-
Best Instant Cash Advance Apps
We’ve compared the best cash advance apps for quick cash — find the right one for your needs.
-
Beyond Finance Review: High Cost Debt Relief
A review of Beyond Finance, a company that offers debt settlement and consolidation loans.
-
How to Save $1,000 a Month
1. Make a budget 2. Create a savings plan 3. Automate savings 4. Pay yourself first 5. Use a high-yield account 6. Do a savings challenge…
-
How to Save $10,000 in a Year
To save $10K: 1. Automate savings 2. Invest 3. Budget 4. Open a high-yield savings account 5. Cut down on spending 6. Pay off debt…
-
Arrowhead Advance Review: High Cost Lender to Avoid
A review of Arrowhead Advance, a tribal lender that charges interest rates up to 830% and has numerous bad reviews.
Ask a question